Founder Intelligence

Thomas Clozel

Advancing technology at Owkin requires rigorous software engineering, disciplined execution, and solving real operational bottlenecks for enterprise users.

Role
Founder
Company
Owkin
Country
France
Company founded
2016
Status
Active

Known for

Owkin provides enterprise-grade artificial intelligence solutions, delivering specialized Owkin Platform technology designed to optimize mission-critical workflows…

Ecosystem Connection Map

How this founder connects across companies, products, industries, and research on Brel.

Overview

Structured founder intelligence — role, focus, and why this person matters in the AI ecosystem.

Thomas Clozel serves as Founder at Owkin in France. Under this leadership, the organization focuses on developing production-grade artificial intelligence systems, enterprise data pipelines, and scalable machine learning workflows designed to solve critical operational bottlenecks.

Why it matters

Thomas Clozel represents executive and engineering leadership in applied artificial intelligence, driving commercialization from foundational research to production software infrastructure.

Career & Timeline

Verified career context from this founder profile.

Role & Leadership at Owkin

As Founder, Thomas Clozel steers the strategic execution, technical roadmap, and architectural foundation of Owkin. The executive mandate encompasses aligning model training architectures, operational deployment protocols, and developer-facing APIs with enterprise compliance and performance benchmarks.

Technical Contributions & Industry Context

Thomas Clozel's technical stewardship at Owkin addresses core infrastructure challenges in the broader AI ecosystem. By prioritizing verifiable model outputs, robust serving infrastructure, and efficient developer integrations, Owkin provides specialized capabilities in modern intelligent computing.

  • Company founded 2016 · founded Owkin was founded in 2016 per the company profile source on file. Source
  • 2016: Owkin co-founded in Paris by Thomas Clozel, MD, and Gilles Wainrib, PhD. 2016 · development Source
  • June 5, 2026: Owkin announced multi-year Sanofi collaboration to co-develop biopharma AI agents backed by a five-year K Pro license. 2026 · development Source
  • May 13, 2026: Owkin announced multi-year K Pro license agreement with AstraZeneca. 2026 · development Source

Companies

Organizations connected to this founder in the Brel graph.

Products

Products and platforms linked to this founder or their organization.

  • Owkin — Biotechnology Biotechnology

    Explore Owkin — Biotechnology by Owkin. Verified AI product intelligence covering core capabilities, Healthcare use cases, technical architecture,…

    View product

Technologies & Expertise

Verified technology terms linked to this founder.

Industries & Use Cases

Sectors and use cases connected to this founder profile.

Ecosystem

Partnerships, acquisitions, and adjacency signals from the connected company graph.

Partnerships

  • June 5, 2026: Owkin announced multi-year Sanofi collaboration to co-develop biopharma AI agents backed by a five-year K Pro license.

Latest Developments

Recent milestones from the connected organization.

  • Development 2016 · development Source

Related Intelligence

Reports and insights editorially linked to this founder.

FAQ

Answers restated from verified fields on this profile.

Who is Thomas Clozel?

Thomas Clozel is a technology leader and entrepreneur currently serving as Founder at Owkin.

What company is Thomas Clozel associated with?

Thomas Clozel is associated with Owkin, leading product and technical initiatives.

Where is Thomas Clozel based?

Thomas Clozel is based in France.

What are Thomas Clozel's key contributions to the industry?

Thomas Clozel focuses on scalable software architecture, enterprise product development, and applied artificial intelligence leadership at Owkin.

Sources & Verification

Verified
Last reviewed Aug 2026

Primary sources

In this profile